301281 科源製藥
按盤價 
41.700 -4.710 (-10.149%)
41.700 -4.710 (-10.149%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.123 | 4.495 | 8.325 | 19.202 | 20.236 |
| 總資產報酬率 ROA (%) | 1.993 | 4.000 | 7.262 | 15.071 | 15.358 |
| 投入資產回報率 ROIC (%) | 1.988 | 4.326 | 8.154 | 18.635 | 19.474 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.082 | 44.269 | 47.252 | 40.936 | 42.101 |
| 營業利潤率 (%) | 9.258 | 14.721 | 17.900 | 22.167 | 21.341 |
| 息稅前利潤/營業總收入 (%) | 10.055 | 13.616 | 16.731 | 21.581 | 21.427 |
| 淨利潤/營業總收入 (%) | 10.328 | 12.998 | 17.212 | 20.611 | 18.573 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 74.849 | 74.028 | 83.434 | 96.574 | 92.525 |
| 價值變動淨收益/利潤總額(%) | 14.445 | 19.690 | 15.983 | 0.000 | 0.000 |
| 營業外收支淨額/利潤總額(%) | 12.275 | -3.887 | -0.478 | 0.131 | 0.107 | 償債能力分析 |
| 流動比率 (X) | 5.627 | 5.766 | 7.907 | 2.617 | 1.836 |
| 速動比率 (X) | 4.284 | 4.690 | 6.935 | 1.987 | 1.056 |
| 資產負債率 (%) | 14.597 | 12.423 | 9.451 | 20.261 | 22.971 |
| 帶息債務/全部投入資本 (%) | 5.388 | 3.926 | -0.520 | -1.119 | -1.590 |
| 股東權益/帶息債務 (%) | 1,729.995 | 2,398.978 | -18,929.749 | -8,633.711 | -6,137.068 |
| 股東權益/負債合計 (%) | 685.091 | 704.511 | 958.081 | 393.551 | 335.331 |
| 利息保障倍數 (X) | -20.163 | -24.601 | -15.447 | -35.060 | 340.459 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 64.692 | 37.654 | 32.438 | 24.031 | 17.141 |
| 存貨周轉天數 (天) | 260.640 | 165.071 | 134.162 | 106.221 | 116.260 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 26/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
